# Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma

> **NCT00006250** · PHASE3 · UNKNOWN · sponsor: **Lymphoma Trials Office** · enrollment: 500 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** chlorambucil
- **DRUG:** dexamethasone
- **DRUG:** fludarabine phosphate
- **DRUG:** mitoxantrone hydrochloride

## Key facts

- **NCT ID:** NCT00006250
- **Lead sponsor:** Lymphoma Trials Office
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006250, "Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00006250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*